mhurhangee/patent-ind-claim-en huggingface dataset:
A device comprising: a breathing circuit , wherein the breathing circuit comprises an inspiratory tube configured to receive an inspiratory gases flow from a gas source , the inspiratory tube comprising an inspiratory inlet , an inspiratory outlet , and a wall enclosing an inspiratory central bore, wherein the inspiratory central bore is smooth; and an expiratory tube configured to receive an expiratory gases flow from a patient , the expiratory tube comprising an expiratory inlet, an expiratory outlet, and a wall enclosing an expiratory central bore, wherein the expiratory central bore is corrugated, and wherein the wall of the expiratory tube is permeable to water vapor and substantially impermeable to liquid water and bulk flow of the expiratory gases flowing therethrough. an inspiratory tube configured to receive an inspiratory gases flow from a gas source , the inspiratory tube comprising an inspiratory inlet , an inspiratory outlet , and a wall enclosing an inspiratory central bore, wherein the inspiratory central bore is smooth; and an expiratory tube configured to receive an expiratory gases flow from a patient , the expiratory tube comprising an expiratory inlet, an expiratory outlet, and a wall enclosing an expiratory central bore, wherein the expiratory central bore is corrugated, and wherein the wall of the expiratory tube is permeable to water vapor and substantially impermeable to liquid water and bulk flow of the expiratory gases flowing therethrough.
A downhole jarring apparatus for use in jarring an object in a bore, comprising: a first jarring portion including a first impact surface ; a second jarring portion including a second impact surface ; characterised by : a rotatable jarring arrangement comprising a pressurising apparatus operable by a rotational drive movement to cause relative axial movement of the first and second impact surfaces to establish axial impact therebetween; wherein the pressurising apparatus provides fluid communication of an actuating fluid between first and second fluid reservoirs , for use in facilitating impact between the first and second impact surfaces . a first jarring portion including a first impact surface ; a second jarring portion including a second impact surface ; a rotatable jarring arrangement comprising a pressurising apparatus operable by a rotational drive movement to cause relative axial movement of the first and second impact surfaces to establish axial impact therebetween; wherein the pressurising apparatus provides fluid communication of an actuating fluid between first and second fluid reservoirs , for use in facilitating impact between the first and second impact surfaces .
A microphone system comprising: a MEMS microphone including a movable membrane having a capacitive electrode configured such that acoustic pressures acting on the movable membrane cause movement of the capacitive electrode, and a first piezoelectric electrode altering a mechanical property of the MEMS microphone based on a control signal, and a backplate positioned on a first side of the movable membrane ; and an electronic controller electrically coupled to the first piezoelectric electrode and configured to generate a first control signal, wherein the movable membrane further has a second piezoelectric electrode altering the mechanical property of the movable membrane based on a second control signal, wherein the first piezoelectric electrode and the second piezoelectric electrode are coupled to a second side opposing the first side of the movable membrane and the control signal comprises the first and second control signal and the controller is further coupled to the second piezoelectric electrode . a MEMS microphone including a movable membrane having a capacitive electrode configured such that acoustic pressures acting on the movable membrane cause movement of the capacitive electrode, and a first piezoelectric electrode altering a mechanical property of the MEMS microphone based on a control signal, and a backplate positioned on a first side of the movable membrane ; and a movable membrane having a capacitive electrode configured such that acoustic pressures acting on the movable membrane cause movement of the capacitive electrode, and a first piezoelectric electrode altering a mechanical property a capacitive electrode configured such that acoustic pressures acting on the movable membrane cause movement of the capacitive electrode, and a first piezoelectric electrode altering a mechanical property of the MEMS microphone based on a control signal, and a backplate positioned on a first side of the movable membrane ; and an electronic controller electrically coupled to the first piezoelectric electrode and configured to generate a first control signal, wherein the movable membrane further has a second piezoelectric electrode altering the mechanical property of the movable membrane based on a second control signal, wherein the first piezoelectric electrode and the second piezoelectric electrode are coupled to a second side opposing the first side of the movable membrane and the control signal comprises the first and second control signal and the controller is further coupled to the second piezoelectric electrode .
A vapour deposition method for preparing an amorphous lithium borosilicate compound or doped lithium borosilicate compound, the method comprising: providing a vapour source of each component element of the compound, wherein the vapour sources comprise at least a source of lithium, a source of oxygen, a source of boron, and a source of silicon, and, optionally, a source of at least one dopant element; providing a substrate at a temperature of less than 180°C; delivering a flow of said lithium, said oxygen, said boron and said silicon, and, optionally, said dopant element, wherein the rate of flow of said oxygen is at least 8 × 10 -8 m 3 /s; and co-depositing the component elements from the vapour sources onto the substrate wherein the component elements react on the substrate to form the amorphous compound; wherein the vapour source of oxygen is vapour source of atomic oxygen. providing a vapour source of each component element of the compound, wherein the vapour sources comprise at least a source of lithium, a source of oxygen, a source of boron, and a source of silicon, and, optionally, a source of at least one dopant element; providing a substrate at a temperature of less than 180°C; delivering a flow of said lithium, said oxygen, said boron and said silicon, and, optionally, said dopant element, wherein the rate of flow of said oxygen is at least 8 × 10 -8 m 3 /s; and co-depositing the component elements from the vapour sources onto the substrate wherein the component elements react on the substrate to form the amorphous compound; wherein the vapour source of oxygen is vapour source of atomic oxygen.
HV cable set , in particular for a vehicle on-board electrical system, having a number of cables which are surrounded by a common shield , and having a connection piece composed of a conductive material, which connection piece is electrically connected to the shield by virtue of the fact that a contact sleeve is integrated into the connection piece , to which contact sleeve the shield is fastened, characterized in that the connection piece is formed as a cast part and the contact sleeve is partially encapsulated by casting in the connection piece .
An extracorporeal circuit for removing CO 2 from blood comprising: a blood withdrawal line for withdrawing blood from the patient, a filtration unit for producing plasma water and a line for returning the blood to the patient, defining a main circuit ; and a decarbonating group comprising a secondary circuit for the recirculation of plasma water, means for removing a fraction of said plasma water and a CO 2 exchanger , characterized in that the secondary circuit further comprises a cationic resin charged with H+ ions set upstream of said CO 2 exchanger and adapted to generate acid plasma water , means for the infusion of said acid plasma water upstream of said CO 2 exchanger and means for the infusion of ions in a solution downstream of said CO 2 exchanger . a blood withdrawal line for withdrawing blood from the patient, a filtration unit for producing plasma water and a line for returning the blood to the patient, defining a main circuit ; and a decarbonating group comprising a secondary circuit for the recirculation of plasma water, means for removing a fraction of said plasma water and a CO 2 exchanger , characterized in that the secondary circuit further comprises a cationic resin charged with H+ ions set upstream of said CO 2 exchanger and adapted to generate acid plasma water , means for the infusion of said acid plasma water upstream of said CO 2 exchanger and means for the infusion of ions in a solution downstream of said CO 2 exchanger .
A system for treating an oral cavity condition, the system comprising: a plant stem cell product comprising an apple stem cell culture lysate; and a mechanical applicator configured to deliver an effective amount of the plant stem cell product to a treatment area in the oral cavity, the mechanical applicator including one or more of an adherent dressing, a tooth-adherent flexible strip, a treatment tray, a brush, a flosser, an electronic-cigarette, or an injection device, wherein the oral cavity condition includes one or more of an oxidative damage, an inflammation, a wound healing, or a cancer. a plant stem cell product comprising an apple stem cell culture lysate; and a mechanical applicator configured to deliver an effective amount of the plant stem cell product to a treatment area in the oral cavity, the mechanical applicator including one or more of an adherent dressing, a tooth-adherent flexible strip, a treatment tray, a brush, a flosser, an electronic-cigarette, or an injection device, wherein the oral cavity condition includes one or more of an oxidative damage, an inflammation, a wound healing, or a cancer.
A nuclear magnetic resonance coil configuration having at least one flat or cylindrical coil , through which current flows in operation, which coil generates in operation a high-frequency magnetic B 1 field at the location of a sample which is oriented parallel to an x-axis, and which for the purpose of connection to a tuning network is connected to at least two electrical feed lines , through which in-phase currents flow in operation, and which generate a high-frequency magnetic B 2 field in the sample , the orientation of which encloses an angle α with the direction of the B 1 field, wherein B 1 field merely means that part of the high-frequency magnetic field, which is generated by the current through the conductors and through possibly integrated capacitors of the coil, but not by the currents through other conductors such as e.g. the feed lines to the coil, wherein the coil consists of a central area in which the highest B 1 field amplitudes are achieved, and an upper and a lower edge region in which the B 1 field drops and its magnitude approaches 0 with or without zero crossing, characterized in that the following applies for the angle α: α = 180 ° ± Δ α , where Δα < 90°, wherein either at least two of the electrical feed lines have a crossing point or at least two of the electrical feed lines are electromagnetically coupled to ring elements in a bottom region of the coil configuration, wherein these ring elements have a crossing point . wherein B 1 field merely means that part of the high-frequency magnetic field, which is generated by the current through the conductors and through possibly integrated capacitors of the coil, but not by the currents through other conductors such as e.g. the feed lines to the coil, wherein the coil consists of a central area in which the highest B 1 field amplitudes are achieved, and an upper and a lower edge region in which the B 1 field drops and its magnitude approaches 0 with or without zero crossing, characterized in that the following applies for the angle α: α = 180 ° ± Δ α , where Δα < 90°, wherein either at least two of the electrical feed lines have a crossing point or at least two of the electrical feed lines are electromagnetically coupled to ring elements in a bottom region of the coil configuration, wherein these ring elements have a crossing point .
A needle shield assembly for a syringe , comprising - an inner needle shield which is flexible and designed to enclose a hollow injection needle of the syringe ; - an outer needle shield which is rigid and designed to enclose a major part of the inner needle shield , which outer needle shield is arranged with a number of passages for allowing sterilizing agents to reach said injection needle during a sterilization process; wherein the needle shield assembly further comprises a cover element (24; 36; 46) arranged adjacent the passages such as to prevent the interior passage of the injection needle from being exposed to oxygen through the passages of the outer needle shield after the sterilization process, wherein the cover element (24; 36; 46) is made of an oxygen-impermeable material, characterized in that the cover element (24; 46) comprises a sleeve (24; 46) arranged to be attached to and cover at least a part of the outer needle shield that comprises the passages , wherein the sleeve is arranged to be attached to and cover at least a part of the outer needle shield . - an inner needle shield which is flexible and designed to enclose a hollow injection needle of the syringe ; - an outer needle shield which is rigid and designed to enclose a major part of the inner needle shield , which outer needle shield is arranged with a number of passages for allowing sterilizing agents to reach said injection needle during a sterilization process; wherein the needle shield assembly further comprises a cover element (24; 36; 46) arranged adjacent the passages such as to prevent the interior passage of the injection needle from being exposed to oxygen through the passages of the outer needle shield after the sterilization process, wherein the cover element (24; 36; 46) is made of an oxygen-impermeable material, characterized in that the cover element (24; 46) comprises a sleeve (24; 46) arranged to be attached to and cover at least a part of the outer needle shield that comprises the passages , wherein the sleeve is arranged to be attached to and cover at least a part of the outer needle shield . wherein the needle shield assembly further comprises a cover element (24; 36; 46) arranged adjacent the passages such as to prevent the interior passage of the injection needle from being exposed to oxygen through the passages of the outer needle shield after the sterilization process, wherein the cover element (24; 36; 46) is made of an oxygen-impermeable material, characterized in that the cover element (24; 46) comprises a sleeve (24; 46) arranged to be attached to and cover at least a part of the outer needle shield that comprises the passages , wherein the sleeve is arranged to be attached to and cover at least a part of the outer needle shield .
An information processing device for providing learning model data to an anomaly detection device that includes memory storing learning model data output from the information processing device and that obtains data flowing over a network and executes anomaly detection of the obtained data based on the learning model data stored in the memory, wherein the information processing device has a processor that executes a data element obtaining step of receiving input of an N count, where N is an integer of 2 or greater, of data elements that are M-dimensional vectors, where M is an integer of 2 or greater, to be used as training data for Isolation Forest, wherein the data elements are obtained from data that flows in the network, a normalization step of normalizing the training data so as to be distributed throughout an M-dimensional first region, a dividing step of dividing an M-dimensional second region that is larger than the first region and encompasses the first region into an L M count, of third regions that are M-dimensional hypercubes of equal sizes, where L is an integer of 4 or greater; a first noise adding step of obtaining, for each of the third regions, a count S, where S is an integer of 0 or greater, of data elements that each of the third regions contains, and with regard to each third region including data elements of a count smaller than a first threshold value T, where T is a natural number, a count of T - S noise elements that are M-dimensional vectors are added with a uniform distribution to the third regions, a generating step of generating noise-added training data including the data elements and noise elements, and a learning model data output step of generating and outputting Isolation Forest learning model data using the noise-added training data.
A method for long-term storage of information comprising the steps of: providing a ceramic substrate ; coating the ceramic substrate with a layer of a second material different from the material of the ceramic substrate , the layer having a thickness no greater than 10 μm; tempering the coated ceramic substrate to form a writable plate ; encoding information on the writable plate by using a laser and/or a focused particle beam to manipulate localized areas of the writable plate . providing a ceramic substrate ; coating the ceramic substrate with a layer of a second material different from the material of the ceramic substrate , the layer having a thickness no greater than 10 μm; tempering the coated ceramic substrate to form a writable plate ; encoding information on the writable plate by using a laser and/or a focused particle beam to manipulate localized areas of the writable plate .
A filter material for inclusion in a smoking article, wherein the filter material consists of fine fibres having a diameter or mean diameter of between 3 μm and 10 μm and wherein the fine fibres comprise cellulose acetate and/or derivatives thereof.
A method for controlling an autonomously driven vehicle, comprising: determining (S103) whether or not a host vehicle (Va) can make a right turn or a left turn while a signal light is still green at a time of the right turn or the left turn is to be made, either while the host vehicle (Va) traveling in the left lane is waiting in a row of vehicles to make the right turn or while the host vehicle (Va) traveling in the right lane is waiting in a row of vehicles to make the left turn at an intersection during travel under autonomous driving; and causing the host vehicle (Va) to creep forward (S105) to a start position for starting at a next time the signal light is green upon determining the right turn or the left turn cannot be made. determining (S103) whether or not a host vehicle (Va) can make a right turn or a left turn while a signal light is still green at a time of the right turn or the left turn is to be made, either while the host vehicle (Va) traveling in the left lane is waiting in a row of vehicles to make the right turn or while the host vehicle (Va) traveling in the right lane is waiting in a row of vehicles to make the left turn at an intersection during travel under autonomous driving; and causing the host vehicle (Va) to creep forward (S105) to a start position for starting at a next time the signal light is green upon determining the right turn or the left turn cannot be made.
A tepoxalin, a tepoxalin derivative or a RWJ20142 derivative for use in treating a subject having a cancer, wherein the treatment comprises: (a) identifying the presence or absence in a subject sample of one or more of the following: high ABCB1 mRNA expression levels, high ABCB1 protein expression levels and/or amplification of the ABCB1 locus; and (b) selecting tepoxalin, a tepoxalin derivative or a RWJ20142 derivative as a treatment for the subject if high ABCB1 mRNA expression levels, high ABCB1 protein expression levels and/or amplification of the ABCB1 locus is observed in the subject sample, thereby selecting a treatment for the subject having a cancer. (a) identifying the presence or absence in a subject sample of one or more of the following: high ABCB1 mRNA expression levels, high ABCB1 protein expression levels and/or amplification of the ABCB1 locus; and (b) selecting tepoxalin, a tepoxalin derivative or a RWJ20142 derivative as a treatment for the subject if high ABCB1 mRNA expression levels, high ABCB1 protein expression levels and/or amplification of the ABCB1 locus is observed in the subject sample, thereby selecting a treatment for the subject having a cancer.
A system comprising: a sample cartridge configured to hold an unprepared sample, the sample cartridge comprising a plurality of processing chambers fluidically interconnected by a moveable valve body; a module configured for performing sample preparation of the sample while disposed within the cartridge, the module having a cartridge receiver adapted to receive and removably couple with the sample cartridge to perform sample preparation and an instrument interface ; and a chip carrier device having a fluidic interface configured for fluidically coupling with the sample cartridge , the fluidic interface being in fluid communication with a flowcell chamber of the device in communication with a chip when carried within a chip carrier portion of the device, wherein the flowcell chamber is adapted to interface with an active area of the chip when carried within the chip carrier portion of the device, wherein the chip carrier portion is configured for supporting a no-leads chip, wherein the chip is configured for performing processing or analysis of the sample when carried within the chip carrier portion of the device, wherein the chip carrier device includes an electrical interface, the electrical interface configured for powering the no-leads chip, when supported within the carrier portion of the device when operably coupled to the sample cartridge , wherein the electrical interface includes a plurality of contacts arranged so as to electrically couple with electrical contacts of the instrument interface . a sample cartridge configured to hold an unprepared sample, the sample cartridge comprising a plurality of processing chambers fluidically interconnected by a moveable valve body; a module configured for performing sample preparation of the sample while disposed within the cartridge, the module having a cartridge receiver adapted to receive and removably couple with the sample cartridge to perform sample preparation and an instrument interface ; and a chip carrier device having a fluidic interface configured for fluidically coupling with the sample cartridge , the fluidic interface being in fluid communication with a flowcell chamber of the device in communication with a chip when carried within a chip carrier portion of the device, wherein the flowcell chamber is adapted to interface with an active area of the chip when carried within the chip carrier portion of the device, wherein the chip carrier portion is configured for supporting a no-leads chip, wherein the chip is configured for performing processing or analysis of the sample when carried within the chip carrier portion of the device, wherein the chip carrier device includes an electrical interface, the electrical interface configured for powering the no-leads chip, when supported within the carrier portion of the device when operably coupled to the sample cartridge , wherein the electrical interface includes a plurality of contacts arranged so as to electrically couple with electrical contacts of the instrument interface .